Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models-Reference-Cited by-同舟云学术

Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models

Published:2022-05-05 Issue:7 Volume:50 Page:968-979
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Qian Yuli,Markowitz John S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference88 articles.

1. Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared With Immediate-release Methylphenidate Chewable Tablet;Abbas;Clin Ther,2016

2. Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers;Adjei;J Child Adolesc Psychopharmacol,2014

3. Aresti-Sanz J Maho W Pereira RR Permentier H El Aidy S pH-dependent spontaneous hydrolysis rather than gut bacterial metabolism reduces levels of the ADHD treatment, Methylphenidate [biRxiv website]. July 2020. Available at: https://www.biorxiv.org/content/10.1101/2020.07.06.189191v1.article-info. Accessed January 27, 2021.

4. Monitoring Marijuana Use in the United States

5. Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions;Pharmaceutics;2024-04-01

2. Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity;Drug Metabolism and Disposition;2024-01-29

3. Drug interactions with Cannabis sativa: Mechanisms and clinical implication;Toxicologie Analytique et Clinique;2023-11

4. A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children;Drug Metabolism and Disposition;2023-03-27

5. Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling;CPT: Pharmacometrics & Systems Pharmacology;2023-01-08